Publications, press articles, rankings, awards
IP5 Statistics Report 2022
Recently, the annual IP5 Statistics Report of the world’s five largest IP offices (IP5) was issued.
Review of French and EU case law relating to pharmaceutical trademarks and designs 2023
Lavoix presents a review of pharmaceutical trademark and design decisions handed down by French and European Union courts.
Form informing applicants about entry of PCT in EP phase discontinued
The EPO has announced that the notice from the EPO informing about the entry into the European phase before the EPO is discontinued.
New edition of the IP Barometer
Created more than 10 years ago to gain a better understanding of developments in intellectual property, the IP Barometer also enables us to develop our services to better meet our clients’ expectations in terms of protecting and enhancing the value of their intangible assets.
Marcuria, an IP law firm joins the Lavoix Group
Lavoix, a major European player in the Intellectual Property (IP) sector, announces the acquisition of Marcuria, a law firm specializing in trademark law, founded by Claire Ardanouy and Emmanuelle Jaeger, both admitted to the Paris Bar and graduated in intellectual property.
Formal entitlement to priority : decision issued by Enlarged Board of Appeal of the EPO
The Enlarged Board of Appeal issued a decision on the consolidated referrals G 1/22 and G 2/22, ruling that the EPO is competent to assess entitlement to priority and that the “PCT joint applicants” approach is valid.